Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) Target Price at $11.97

Teladoc Health, Inc. (NYSE:TDOC) has earned an average rating of “Hold” from the twenty-one brokerages that are currently covering the stock, Marketbeat.com reports. Fourteen investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $12.08.

A number of research analysts recently commented on the company. Jefferies Financial Group boosted their price target on Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research note on Tuesday, September 17th. The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a research report on Friday. They set a “buy” rating and a $14.00 price target on the stock. Piper Sandler lowered their price objective on shares of Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a research report on Tuesday, August 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $10.00 target price on shares of Teladoc Health in a report on Tuesday, August 20th. Finally, DA Davidson lowered their price target on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a report on Thursday, August 1st.

Teladoc Health Stock Performance

Shares of NYSE:TDOC opened at $9.20 on Wednesday. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $22.54. The company’s 50 day moving average price is $8.89 and its two-hundred day moving average price is $9.41. The firm has a market cap of $1.58 billion, a PE ratio of -1.59 and a beta of 0.90. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The firm had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Equities research analysts predict that Teladoc Health will post -1.19 earnings per share for the current year.

Insider Buying and Selling at Teladoc Health

In related news, COO Michael Willem Waters sold 4,218 shares of Teladoc Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the transaction, the chief operating officer now directly owns 78,309 shares of the company’s stock, valued at $560,692.44. The trade was a 5.11 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Mala Murthy sold 8,750 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now directly owns 85,767 shares of the company’s stock, valued at $614,091.72. This represents a 9.26 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 20,051 shares of company stock worth $143,565. 0.95% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Y Intercept Hong Kong Ltd bought a new position in shares of Teladoc Health during the 3rd quarter worth approximately $152,000. Quantinno Capital Management LP lifted its position in shares of Teladoc Health by 190.4% during the 3rd quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider’s stock valued at $1,709,000 after acquiring an additional 122,050 shares during the period. Point72 Asset Management L.P. lifted its position in shares of Teladoc Health by 57.8% during the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after acquiring an additional 3,063,172 shares during the period. Parker Investment Management LLC boosted its stake in Teladoc Health by 142.2% during the third quarter. Parker Investment Management LLC now owns 57,213 shares of the health services provider’s stock worth $525,000 after acquiring an additional 33,592 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. acquired a new stake in Teladoc Health in the third quarter worth $11,291,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.